297 related articles for article (PubMed ID: 32226008)
1. Cost of interventions to control schistosomiasis: A systematic review of the literature.
Salari P; Fürst T; Knopp S; Utzinger J; Tediosi F
PLoS Negl Trop Dis; 2020 Mar; 14(3):e0008098. PubMed ID: 32226008
[TBL] [Abstract][Full Text] [Related]
2. Assessment of global guidelines for preventive chemotherapy against schistosomiasis and soil-transmitted helminthiasis: a cost-effectiveness modelling study.
Lo NC; Lai YS; Karagiannis-Voules DA; Bogoch II; Coulibaly JT; Bendavid E; Utzinger J; Vounatsou P; Andrews JR
Lancet Infect Dis; 2016 Sep; 16(9):1065-1075. PubMed ID: 27286968
[TBL] [Abstract][Full Text] [Related]
3. The cost of a school based mass treatment of schistosomiasis in Ugu District, KwaZulu Natal, South Africa in 2012.
Maphumulo A; Mahomed O; Vennervald B; Gundersen SG; Taylor M; Kjetland EF
PLoS One; 2020; 15(6):e0232867. PubMed ID: 32497049
[TBL] [Abstract][Full Text] [Related]
4. Health, financial, and education gains of investing in preventive chemotherapy for schistosomiasis, soil-transmitted helminthiases, and lymphatic filariasis in Madagascar: A modeling study.
De Neve JW; Andriantavison RL; Croke K; Krisam J; Rajoela VH; Rakotoarivony RA; Rambeloson V; Schultz L; Qamruddin J; Verguet S
PLoS Negl Trop Dis; 2018 Dec; 12(12):e0007002. PubMed ID: 30589847
[TBL] [Abstract][Full Text] [Related]
5. Controlling schistosomiasis: the cost-effectiveness of alternative delivery strategies.
Guyatt H; Evans D; Lengeler C; Tanner M
Health Policy Plan; 1994 Dec; 9(4):385-95. PubMed ID: 10139471
[TBL] [Abstract][Full Text] [Related]
6. Factors affecting the uptake of preventive chemotherapy treatment for schistosomiasis in Sub-Saharan Africa: A systematic review.
Torres-Vitolas CA; Dhanani N; Fleming FM
PLoS Negl Trop Dis; 2021 Jan; 15(1):e0009017. PubMed ID: 33465076
[TBL] [Abstract][Full Text] [Related]
7. Utility of repeated praziquantel dosing in the treatment of schistosomiasis in high-risk communities in Africa: a systematic review.
King CH; Olbrych SK; Soon M; Singer ME; Carter J; Colley DG
PLoS Negl Trop Dis; 2011 Sep; 5(9):e1321. PubMed ID: 21949893
[TBL] [Abstract][Full Text] [Related]
8. An inclusive dose pole for treatment of schistosomiasis in infants and preschool children with praziquantel.
Sousa-Figueiredo JC; Day M; Betson M; Kabatereine NB; Stothard JR
Trans R Soc Trop Med Hyg; 2010 Nov; 104(11):740-2. PubMed ID: 20832093
[TBL] [Abstract][Full Text] [Related]
9. Improving control of African schistosomiasis: towards effective use of rapid diagnostic tests within an appropriate disease surveillance model.
Stothard JR
Trans R Soc Trop Med Hyg; 2009 Apr; 103(4):325-32. PubMed ID: 19171359
[TBL] [Abstract][Full Text] [Related]
10. The cost of large-scale school health programmes which deliver anthelmintics to children in Ghana and Tanzania. The Partnership for Child Development.
Acta Trop; 1999 Jul; 73(2):183-204. PubMed ID: 10465058
[TBL] [Abstract][Full Text] [Related]
11. Optimising cluster survey design for planning schistosomiasis preventive chemotherapy.
Knowles SCL; Sturrock HJW; Turner H; Whitton JM; Gower CM; Jemu S; Phillips AE; Meite A; Thomas B; Kollie K; Thomas C; Rebollo MP; Styles B; Clements M; Fenwick A; Harrison WE; Fleming FM
PLoS Negl Trop Dis; 2017 May; 11(5):e0005599. PubMed ID: 28552961
[TBL] [Abstract][Full Text] [Related]
12. The presumptive treatment of all school-aged children is the least costly strategy for schistosomiasis control in Plateau and Nasarawa states, Nigeria.
Gutman J; Richards FO; Eigege A; Umaru J; Alphonsus K; Miri ES
Ann Trop Med Parasitol; 2009 Sep; 103(6):501-11. PubMed ID: 19695155
[TBL] [Abstract][Full Text] [Related]
13. Potential cost-effectiveness of schistosomiasis treatment for reducing HIV transmission in Africa--the case of Zimbabwean women.
Ndeffo Mbah ML; Poolman EM; Atkins KE; Orenstein EW; Meyers LA; Townsend JP; Galvani AP
PLoS Negl Trop Dis; 2013; 7(8):e2346. PubMed ID: 23936578
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of pediatric schistosomiasis in hard-to-reach areas and populations: A scoping review protocol.
Isaiah PM; Palmeirim MS; Steinmann P
F1000Res; 2022; 11():1203. PubMed ID: 36761831
[No Abstract] [Full Text] [Related]
15. Schistosomiasis in school-age children in Burkina Faso after a decade of preventive chemotherapy.
Ouedraogo H; Drabo F; Zongo D; Bagayan M; Bamba I; Pima T; Yago-Wienne F; Toubali E; Zhang Y
Bull World Health Organ; 2016 Jan; 94(1):37-45. PubMed ID: 26769995
[TBL] [Abstract][Full Text] [Related]
16. Determining treatment needs at different spatial scales using geostatistical model-based risk estimates of schistosomiasis.
Schur N; Vounatsou P; Utzinger J
PLoS Negl Trop Dis; 2012; 6(9):e1773. PubMed ID: 23029570
[TBL] [Abstract][Full Text] [Related]
17. Time to set the agenda for schistosomiasis elimination.
Rollinson D; Knopp S; Levitz S; Stothard JR; Tchuem Tchuenté LA; Garba A; Mohammed KA; Schur N; Person B; Colley DG; Utzinger J
Acta Trop; 2013 Nov; 128(2):423-40. PubMed ID: 22580511
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness analysis of the impacts on infection and morbidity attributable to three chemotherapy schemes against Schistosoma japonicum in hyperendemic areas of the Dongting Lake region, China.
Yu D; Sarol JN; Hutton G; Tan D; Tanner M
Southeast Asian J Trop Med Public Health; 2002 Sep; 33(3):441-57. PubMed ID: 12693575
[TBL] [Abstract][Full Text] [Related]
19. Schistosomiasis Prevalence and Intensity of Infection in Latin America and the Caribbean Countries, 1942-2014: A Systematic Review in the Context of a Regional Elimination Goal.
Zoni AC; Catalá L; Ault SK
PLoS Negl Trop Dis; 2016 Mar; 10(3):e0004493. PubMed ID: 27007193
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
